Journal of Dermatology Research · Aug 29, 2026

The Inflammaging Paradox in Aesthetic Surgery: How Systemic Senescence Blunts the Efficacy of Energy-Based Devices and Tissue Repair

By Gupta SC, Gupta S

Background: “Inflammaging”, a chronic, low-grade, sterile, systemic inflammatory state that intensifies with chronological age, is increasingly recognized as a unifying driver of tissue-level aging across organ systems, yet its implications for aesthetic and reconstructive surgical outcomes have not been systematically mapped. Cellular senescence, Senescence-Associated Secretory Phenotype (SASP) activity and a progressive shift toward matrix-degrading proteolysis are each individually documented in the dermatology and gerontology literatures, but the aesthetic surgery literature has not yet synthesized how these processes converge to alter the host tissue bed that surgeons depend upon for successful outcomes. Objective: To map the existing literature on inflammaging as it pertains to (1) the pathophysiology of facial soft-tissue aging, (2) wound healing and scar formation, (3) the efficacy and complication profile of controlled-injury aesthetic modalities (ablative/fractional resurfacing, radiofrequency microneedling, chemical peels) and (4) emerging strategies for “aesthetic prehabilitation” and to identify the research gaps that must be closed before host-tissue optimization can be adopted as a standard adjunct to aesthetic surgical planning. Methods: A scoping review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) framework. Twelve structured search strings across five thematic concept clusters were run in PubMed/MEDLINE on July 25, 2026, yielding 12,138 database records; 11 additional records were identified through citation chasing. Given the scale of some search yields, a relevance-ranked screening protocol (typically the top 40-50 records per search string) was applied and is disclosed transparently as a resource-constrained rapid-review adaptation rather than exhaustive screening of all raw hits. In total, 433 records were screened, 333 were excluded and 111 records were assessed at the eligibility stage, of which 110 were included in the final synthesis. Discussion/Conclusion: The reviewed evidence supports a coherent model in which senescent dermal fibroblasts, keratinocytes and adipocytes secrete a chronic SASP that shifts the Matrix Metalloproteinase (MMP)/Tissue Inhibitor of Metalloproteinase (TIMP) balance toward net proteolysis, destabilizes the Superficial Musculoaponeurotic System (SMAS) and facial fat compartments, stalls the macrophage M1-to-M2 transition central to wound repair and predisposes to pathologic cicatrization via sustained Transforming Growth Factor-Beta 1 (TGF-β1) signaling. Because controlled-injury aesthetic modalities depend on an intact, temporally coordinated healing response, this inflammaging phenotype plausibly explains the disproportionate erythema, textural change and unpredictable neocollagenesis observed in aged and photodamaged skin-though the device-outcomes literature rarely stratifies by chronological age or senescent burden, a limitation this review makes explicit. “Aesthetic prehabilitation”, combining topical senotherapeutics/regenerative biomaterials, systemic metabolic optimization and staged procedural timing, is conceptually well supported by adjacent oncologic and cardiac prehabilitation evidence but remains almost entirely untested as a named, protocolized intervention in aesthetic surgery. Validated point-of-care biomarkers of inflammaging are similarly absent from the aesthetic-surgery literature. These converging gaps define a clear translational research agenda: standardized aesthetic prehabilitation protocols, age- and senescence-stratified device-outcome trials and biomarker-driven patient selection represent the next frontier for optimizing the host tissue bed rather than treating it as biologically inert.

doi.org/10.46889/jdr.2026.7215Open accessMechanisms

AgingResearch.News